01 August 2024
01 August 2024
OrbusNeich and Boston Scientific are among the key players in the percutaneous transluminal coronary angioplasty balloon catheter space.
In a Q2 earnings report, revenue growth for the year was cut from 4% to a range of 1%-2%.
The transaction will involve payment through the issuance of BioSig’s common stock to NKC shareholders.
The trial will enrol 150 paediatric participants across three sites in the UK and will follow up on their surgical outcomes for up to one year.
BURL Concepts has submitted the SONAS IDE application to the US Food and Drug Administration.
The San Francisco-based company unveiled data showing that the patch addresses limitations associated with traditional wearable defibrillators.
AVITA will have exclusive marketing, sales, and distribution rights for the dermal matrix in the US.
The ARx SAI Spinal Fixation System includes versatile implants and ergonomic instrumentation.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.
